A Data-Driven Breakthrough
The research, conducted by an international team from MIT, the University of Cambridge, and a biotech startup named NeuraCure, used advanced machine learning models to sift through decades of Alzheimer’s-related genomic, proteomic, and clinical data. The AI uncovered a previously overlooked interaction between a specific protein known as PTK7 and neural inflammation markers in the brain.